Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children
Objectives To develop evidence-based recommendations for clinicians caring for children
(including infants, school-aged children, and adolescents) with septic shock and other …
(including infants, school-aged children, and adolescents) with septic shock and other …
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …
[PDF][PDF] Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020
World Health Organization… - World Health …, 2020 - covid-19.conacyt.mx
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is
suspected Page 1 -1- Clinical management of severe acute respiratory infection (SARI) when …
suspected Page 1 -1- Clinical management of severe acute respiratory infection (SARI) when …
[HTML][HTML] Therapeutic management of patients with COVID-19: a systematic review
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which was declared a global …
causative agent of coronavirus disease 2019 (COVID-19), which was declared a global …
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - Elsevier
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
[HTML][HTML] The global burden of sepsis and septic shock
A dysregulated host response to infection causes organ dysfunction in sepsis and septic
shock, two potentially fatal diseases. They continue to be major worldwide health burdens …
shock, two potentially fatal diseases. They continue to be major worldwide health burdens …
[HTML][HTML] Cardiac manifestations of coronavirus (COVID-19)
Cardiac Manifestations of Coronavirus (COVID-19) - StatPearls - NCBI Bookshelf US flag An
official website of the United States government Here's how you know NIH NLM Logo Access …
official website of the United States government Here's how you know NIH NLM Logo Access …
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection has posed the world at a pandemic risk. Coronavirus-19 disease (COVID-19) is an …
infection has posed the world at a pandemic risk. Coronavirus-19 disease (COVID-19) is an …